These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19796686)

  • 1. LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology.
    Owuor K; Harel NY; Englot DJ; Hisama F; Blumenfeld H; Strittmatter SM
    Mol Cell Neurosci; 2009 Dec; 42(4):448-57. PubMed ID: 19796686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11.
    Sagane K; Ishihama Y; Sugimoto H
    Int J Biol Sci; 2008; 4(6):387-96. PubMed ID: 18974846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion-Positive LGI1 Mutations Linked to Lateral Temporal Epilepsy Impair Binding to ADAM22 and ADAM23 Receptors.
    Dazzo E; Leonardi E; Belluzzi E; Malacrida S; Vitiello L; Greggio E; Tosatto SC; Nobile C
    PLoS Genet; 2016 Oct; 12(10):e1006376. PubMed ID: 27760137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors.
    Ohkawa T; Fukata Y; Yamasaki M; Miyazaki T; Yokoi N; Takashima H; Watanabe M; Watanabe O; Fukata M
    J Neurosci; 2013 Nov; 33(46):18161-74. PubMed ID: 24227725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy.
    Fukata Y; Lovero KL; Iwanaga T; Watanabe A; Yokoi N; Tabuchi K; Shigemoto R; Nicoll RA; Fukata M
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3799-804. PubMed ID: 20133599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM23 is a negative regulator of K
    Lancaster E; Burnor E; Zhang J; Lancaster E
    Neurosci Lett; 2019 Jun; 704():159-163. PubMed ID: 30965109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission.
    Fukata Y; Adesnik H; Iwanaga T; Bredt DS; Nicoll RA; Fukata M
    Science; 2006 Sep; 313(5794):1792-5. PubMed ID: 16990550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.
    Lai M; Huijbers MG; Lancaster E; Graus F; Bataller L; Balice-Gordon R; Cowell JK; Dalmau J
    Lancet Neurol; 2010 Aug; 9(8):776-85. PubMed ID: 20580615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.
    Petit-Pedrol M; Sell J; Planagumà J; Mannara F; Radosevic M; Haselmann H; Ceanga M; Sabater L; Spatola M; Soto D; Gasull X; Dalmau J; Geis C
    Brain; 2018 Nov; 141(11):3144-3159. PubMed ID: 30346486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM22 and ADAM23 modulate the targeting of the Kv1 channel-associated protein LGI1 to the axon initial segment.
    Hivert B; Marien L; Agbam KN; Faivre-Sarrailh C
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30598502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 proteins stabilize LGI1-ADAM22 levels to regulate seizure thresholds in mice.
    Yokoi N; Fukata Y; Okatsu K; Yamagata A; Liu Y; Sanbo M; Miyazaki Y; Goto T; Abe M; Kassai H; Sakimura K; Meijer D; Hirabayashi M; Fukai S; Fukata M
    Cell Rep; 2021 Dec; 37(11):110107. PubMed ID: 34910912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM23, a Gene Related to LGI1, Is Not Linked to Autosomal Dominant Lateral Temporal Epilepsy.
    Rigon L; Vettori A; Busolin G; Egeo G; Pulitano P; Santulli L; Pasini E; Striano P; la Neve A; Vianello Dri V; Boniver C; Gambardella A; Banfi P; Binelli S; Di Bonaventura C; Striano S; de Falco F; Giallonardo AT; Mecarelli O; Michelucci R; Nobile C
    Epilepsy Res Treat; 2011; 2011():258365. PubMed ID: 22937229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the mechanisms of epilepsy from structural biology of LGI1-ADAM22.
    Yamagata A; Fukai S
    Cell Mol Life Sci; 2020 Jan; 77(2):267-274. PubMed ID: 31432233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LGI1-ADAM22-MAGUK configures transsynaptic nanoalignment for synaptic transmission and epilepsy prevention.
    Fukata Y; Chen X; Chiken S; Hirano Y; Yamagata A; Inahashi H; Sanbo M; Sano H; Goto T; Hirabayashi M; Kornau HC; Prüss H; Nambu A; Fukai S; Nicoll RA; Fukata M
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy.
    Yokoi N; Fukata Y; Kase D; Miyazaki T; Jaegle M; Ohkawa T; Takahashi N; Iwanari H; Mochizuki Y; Hamakubo T; Imoto K; Meijer D; Watanabe M; Fukata M
    Nat Med; 2015 Jan; 21(1):19-26. PubMed ID: 25485908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGI1: from zebrafish to human epilepsy.
    Cowell JK
    Prog Brain Res; 2014; 213():159-79. PubMed ID: 25194489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
    Ramberger M; Berretta A; Tan JMM; Sun B; Michael S; Yeo T; Theorell J; Bashford-Rogers R; Paneva S; O'Dowd V; Dedi N; Topia S; Griffin R; Ramirez-Franco J; El Far O; Baulac S; Leite MI; Sen A; Jeans A; McMillan D; Marshall D; Anthony D; Lightwood D; Waters P; Irani SR
    Brain; 2020 Jun; 143(6):1731-1745. PubMed ID: 32437528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-synaptic LGI1-ADAM22-MAGUK in AMPA and NMDA receptor regulation.
    Fukata Y; Hirano Y; Miyazaki Y; Yokoi N; Fukata M
    Neuropharmacology; 2021 Aug; 194():108628. PubMed ID: 34089731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LGI1-ADAM22 protein complex in synaptic transmission and synaptic disorders.
    Fukata Y; Yokoi N; Miyazaki Y; Fukata M
    Neurosci Res; 2017 Mar; 116():39-45. PubMed ID: 27717669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition.
    Thomas R; Favell K; Morante-Redolat J; Pool M; Kent C; Wright M; Daignault K; Ferraro GB; Montcalm S; Durocher Y; Fournier A; Perez-Tur J; Barker PA
    J Neurosci; 2010 May; 30(19):6607-12. PubMed ID: 20463223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.